Tower Research Capital LLC (Trc) Ironwood Pharmaceuticals Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,524 shares of IRWD stock, worth $29,905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,524
Previous 28,002
65.99%
Holding current value
$29,905
Previous $20,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding IRWD
# of Institutions
186Shares Held
160MCall Options Held
11.2MPut Options Held
11.7K-
Black Rock Inc. New York, NY22.9MShares$71.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$50.7 Million0.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$50.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$50 Million13.13% of portfolio
-
Bank Of America Corp Charlotte, NC11.7MShares$36.7 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $481M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...